Incyte (INCY) Change in Accured Expenses (2010 - 2026)

Incyte (INCY) posted Change in Accured Expenses of -$84.7 million for Q1 2026, down 161.15% on a QoQ basis from $138.5 million in Q4 2025, and down 213.21% year-over-year from $74.8 million in Q1 2025.

Incyte (INCY) Change in Accured Expenses (2010 - 2026) Analysis & Trends

Incyte's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$84.7 million for Q1 2026.

  • Quarterly Change in Accured Expenses fell 213.21% year-over-year to -$84.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$307.8 million (down 223.94% YoY) and the FY2025 annual result came in at -$148.2 million, down 153.13% from the prior year.
  • Change in Accured Expenses was -$84.7 million for Q1 2026 at Incyte, down from $138.5 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $138.5 million in Q4 2025 and bottomed at -$476.7 million in Q2 2025.
  • A 5-year average of $29.2 million and a median of $71.9 million in 2023 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2022 — Change in Accured Expenses surged 2430.46% — and 2025, when it tumbled 510.9%.
  • Incyte's Change in Accured Expenses stood at $47.8 million in 2022, then soared by 143.08% to $116.2 million in 2023, then climbed by 11.66% to $129.8 million in 2024, then advanced by 6.76% to $138.5 million in 2025, then plunged by 161.15% to -$84.7 million in 2026.
  • Business Quant data shows INCY's Change in Accured Expenses at -$84.7 million in Q1 2026, $138.5 million in Q4 2025, and $115.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Oculis Holding AG 69,146.49 Bn 69,146.20 Bn - 1.13 Mn
2 Nanobiotix 1,942.19 Bn 1,942.13 Bn - -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn - 931,000.00
4 BeOne Medicines 475.42 Bn 470.63 Bn 1.35 Bn -16.82 Mn
5 Vertex Pharmaceuticals 123.32 Bn 116.08 Bn 2.59 Bn 23.10 Mn
6 Regeneron Pharmaceuticals 69.80 Bn 61.04 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 63.28 Bn 63.28 Bn - -
8 Argenx Se 56.67 Bn 51.48 Bn 1.41 Bn -
9 Revolution Medicines 38.15 Bn 38.15 Bn - -16.74 Mn
10 Incyte 23.92 Bn 19.90 Bn 1.17 Bn -84.73 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -84.73 Mn
Mar 31, 2026 -84.73 Mn
Dec 31, 2025 138.55 Mn
Dec 31, 2025 138.55 Mn
Sep 30, 2025 115.14 Mn
Sep 30, 2025 115.14 Mn
Jun 30, 2025 -476.73 Mn
Jun 30, 2025 -476.73 Mn
Mar 31, 2025 74.84 Mn
Mar 31, 2025 74.84 Mn
Dec 31, 2024 129.77 Mn
Dec 31, 2024 129.77 Mn
Sep 30, 2024 121.74 Mn
Sep 30, 2024 121.74 Mn
Jun 30, 2024 -78.04 Mn
Jun 30, 2024 -78.04 Mn
Mar 31, 2024 105.47 Mn
Mar 31, 2024 105.47 Mn
Dec 31, 2023 116.22 Mn
Dec 31, 2023 116.22 Mn